Back to top
more

VanEck Pharmaceutical ETF: (PPH)

(Delayed Data from NASDAQ) As of Nov 16, 2026 04:00 PM ET

$121.59 USD

121.59
197,323

-1.06 (-0.86%)

Volume: 197,323

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

Zacks News

Aparajita Dutta headshot

ETFs in Spotlight as FDA Vision Loss Warning Meets Lilly's Sleep Apnea Win

Eli Lilly's sleep apnea breakthrough amid the FDA's vision-loss warning puts diversified healthcare ETFs in the spotlight.

Zacks Equity Research

Execution of Pharma Tariffs Brings These ETFs Into Focus

Trump's 100% pharma tariff is reshaping the drug industry. Here's how the key pharma ETFs could be affected.

Zacks Equity Research

Here's How Trump's Drug Deals Are Likely to Impact Healthcare ETFs

Trump's latest MFN drug-pricing deals create a mixed outlook for the broader healthcare sector ETFs.

Zacks Equity Research

Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough

Merck-Moderna's melanoma vaccine success could boost immunotherapy growth, putting healthcare ETFs in the spotlight.

Aparajita Dutta headshot

FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now

FDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market and four healthcare ETFs to watch.

Zacks Equity Research

Will Generic Drug Tariffs Impact Pharma ETFs?

New U.S. tariffs on generic drugs could pressure drugmakers and influence pharmaceutical ETFs. Here's what investors should watch.

Sanghamitra Saha headshot

4 ETF Winners of June Likely to Gain in July

These ETF gainers of June may keep climbing in July as dovish Fed hopes, strong earnings and easing geopolitical risks support markets.

Sanghamitra Saha headshot

Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market

GLP-1 drugs are reshaping healthcare and consumer markets. These ETFs offer targeted exposure to the booming obesity-drug trend.